Treatment Outcome of Short Implant Assisted Mandibular Overdenture

Sponsor
Sara Zayed (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03540316
Collaborator
(none)
12
1
4
68
0.2

Study Details

Study Description

Brief Summary

This study evaluates the use of short dental implants to support mandibular overdenture together with the use of laser therapy for treatment of patients with atrophic ridges. All participants will receive laser therapy; half of participants will receive two short implants and the other half will receive four short implants.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: Two short implants and 2 minutes LLLT
  • Combination Product: Two short implants and 4 minutes LLLT
  • Combination Product: Four short implants and 2 minutes LLLT
  • Combination Product: Four short implants and 4 minutes LLLT
N/A

Detailed Description

The conventional solution to complete edentulism is the use of complete removable dentures. One negative effect of edentulism is resorption of the edentulous ridge over time. Construction of a successful mandibular complete denture for patients with advanced mandibular ridge resorption is often difficult and on some occasions virtually impossible. It has been proved that when implants are placed, bone gets stimulated resulting in minimal bone loss. But anatomic limitations to implant placement have been observed in atrophic ridges, so short implants introduced as a recent alternative to aggressive surgical procedures proposed to compensate for tissue deficiency. Also, Low Level Laser Therapy (LLLT) has proven success in improving implant stability which is very crucial in short implants. Thus, the purpose of this study is to evaluate and compare the treatment outcome of mandibular overdenture assisted by two short implants versus that assisted by four short implants in combination with LLLT.

Study Design

Study Type:
Interventional
Actual Enrollment :
12 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Treatment Outcome of Short Implant Assisted Mandibular Overdenture in Combination With Low Level Laser Therapy
Actual Study Start Date :
May 1, 2018
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Two short implants and 2 minutes LLLT

Patients receiving 2 short dental implants assisted mandibular over-denture and Low level laser therapy (LLLT) for 2 minutes .

Combination Product: Two short implants and 2 minutes LLLT
Patients with edentulous atrophied mandibular ridge will receive 2 short dental implants and LLLT for 2 minutes.

Active Comparator: Two short implants and 4 minutes LLLT

Patients receiving 2 short dental implants assisted mandibular over-denture and LLLT for 2 minutes .

Combination Product: Two short implants and 4 minutes LLLT
Patients with edentulous atrophied mandibular ridge will receive 2 short dental implants and LLLT for 4 minutes.

Active Comparator: Four short implants and 2 minutes LLLT

Patients receiving 4 short dental implants assisted mandibular over-denture and LLLT for 2 minutes .

Combination Product: Four short implants and 2 minutes LLLT
Patients with edentulous atrophied mandibular ridge will receive 4 short dental implants and LLLT for 2 minutes.

Active Comparator: Four short implants and 4 minutes LLLT

Patients receiving 4 short dental implants assisted mandibular over-denture and LLLT for 4 minutes .

Combination Product: Four short implants and 4 minutes LLLT
Patients with edentulous atrophied mandibular ridge will receive 4 short dental implants and LLLT for 4 minutes.

Outcome Measures

Primary Outcome Measures

  1. Assessment of changes in implant stability (Implant Stability Quotient). [Baseline, 6 months &12 months.]

    Implant stability can be defined as the absence of clinical mobility. It will be assessed at the time of implant placement (baseline) ,then six months and twelve months later, by the resonance frequency analysis using Osstel devise which measure implant oscillation frequency on the bone;Implant Stability Quotient (ISQ) .

Secondary Outcome Measures

  1. Peri-implant marginal bone changes. [Baseline, 6 months &12 months.]

    Radiographic assessment of bone level changes around each implant will be performed to detect peri-implant crestal bone changes using standardised digital periapical x-ray. It will be assessed at the time of implant placement, six months and twelve months later.

  2. Assessment of changes in peri-implant probing depth . [Baseline, 6 months &12 months.]

    Peri-implant probing depth is the distance between the gingival margin and the most apically probeable portion, in millimetres. It will be measured at four sites of each implant (mesially, labially, distally, lingually) by using a graduated periodontal probe which will be held parallel to the long axis of the implant and introduced to the peri-implant sulcus till there is slight resistance. The mean record for each implant will be calculated. It will be evaluated at time of definitive prosthesis insertion then, six months and twelve months after implant placement.

  3. Assessment of changes in modified gingival index [Baseline, 6 months &12 months.]

    To qualify the degree of peri-implant inflammation, the modified gingival index will be used. It will be measured at four sites around each implant (mesially, labially, distally, lingually) and the mean record for each implant will be calculated. It will be evaluated at time of definitive prosthesis insertion, then six months and twelve months after implant placement.

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 65 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Completely edentulous patients.

  • Patients with mandibular resorbed edentulous ridge.

  • Medically fit patients with no systemic conditions.

  • Class I ridge relation.

  • Adequate zone of keratinized mucosa.

Exclusion Criteria:
  • Metabolic bone disease or unstable systemic condition.

  • Heavy smokers.

  • A history of radiotherapy in the head and neck region.

  • Physical or mental disability.

  • Temporomandibular and neuromuscular disorders.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of dentistry Alexandria Egypt

Sponsors and Collaborators

  • Sara Zayed

Investigators

  • Study Director: Sara Zayed, Alexandria University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sara Zayed, Director, Alexandria University
ClinicalTrials.gov Identifier:
NCT03540316
Other Study ID Numbers:
  • 01032018
First Posted:
May 30, 2018
Last Update Posted:
Jul 27, 2021
Last Verified:
Jul 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2021